| dc.relation | /*ref*/Cammarata-Scalisi F, Camacho N. Distrofia Muscular de Duchenne, presentación clínica. Rev Chil Pediatr. 2008;79(5):495-501. 2. Tsao C Y, Mendell J R: Coexisting muscular dystrophies and epilepsy in children. J Child Neurol. 2006;21:148-50. 3. Bushby K, Finkel R. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77-93. 4. López-Hernández L, Vázquez-Cárdenas N. Distrofia muscular de Duchenne: actualidad y perspectivas de tratamiento. Rev Neurol. 2009;49(7):369-75. 5. Bushby KM, Hill A, Steele J G. Failure of early diagnosis in symptomatic Duchenne muscular dystrophy. Lancet. 1999;353:55-78. 6. Darras B T, Menache C C, Kunkel L M. Dystrophinopathies. In: Jones HR, DeVivo DC, Darras BT, eds. Neuromuscular Disorders of Infancy, Childhood, and Adolescence—A Clinician’s Approach. Amsterdam: Butterworth Heinemann. 2003:649-700. 7. Meryon E. On granular and fatty degeneration of the voluntary muscles. Medico-Chirurgical Transactions. 1852;35:73-84. 8. Duchenne GBA. Recherches sur la paralysiemusculairepseudohypertrophiqueouparalysiemyo-sclérosique. Archives Générales de Médecine 1868; 11:5–25, 179–209, 305–321, 421–443, 552–588. 9. Chamberlain J, Rando T. Duchenne Muscular Distrophy, Advances in Therapeutics. Taylor and Francis Group. New York, 2006. 10. Hoffman E P, Brown R H Jr, Kunkel L M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919-28. 11. Davies KE, Nowak KJ. Molecular mechanisms of muscular dystrophies: old and new players. Nat Rev Mol Cell Biol. 2006;7:762-73. 12. Deconinck N, Dan B. Pathophysiology of Duchenne muscular dystrophy: current hypotheses. Pediatr Neurol. 2007;36:1-7. 13. Erazo-Torricelli R. Actualización en distrofias musculares. Rev Neurol. 2004;39:860-71. 14. Labarque V, Freson K. Increased Gssignalling in platelets and impaired collagen activation, due to a defect in the dystrophin gene, result in increased blood loss during spinal surgery. Hum Mol Genet. 2008;17:357-66. 15. Ciafaloni E, Fox D J, Pandya S. Delayed diagnosis in Duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr. 2009;155:380-5. 16. Darras BT, Menache CC. Neuromuscular Disorders of Infancy, Childhood, and Adolescence—A Clinician’s Approach. Amsterdam: Butterworth Heinemann. 2003:649-700. 17. Biggar WD. Duchenne muscular dystrophy. Pediatr Rev. 2006;27:83-8. 18. Hoffman E P. Dystrophinopathies. In: Karpati G, Hilton-Jones D, Griggs RC, eds. Disorders of Voluntary Muscle. Cambridge: Cambridge University Press, 2001:385–482. 19. Brooke MH, Fenichel GM, Griggs RC, et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology. 1989;39(4):475-81. 20. Finder JCCP. Respiratory care of the patient with Duchenne muscular dystrophy: an official ATS consensus statement. Am J Respir Crit Care Med. 2004;170(4):456-65. 21. Phillips M F, Quinlivan R C, Edwards R H, Calverley P M. Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med. 2001;164:2191-4. 22. Bensen E S, Jaffe K M, Tarr P I. Acute gastric dilatation in Duchenne muscular dystrophy: a case report and review of the literature. Arch Phys Med Rehabil. 1996;77(5):512-4. 23. Boland B J, Silbert P L, Groover R V, Wollan P C, Silverstein M D. Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy. Pediatr Neurol. 1996;14(1):7-12. 24. Verma S, Anziska Y. Review of Duchenne Muscular Dystrophy (DMD) for the Pediatricians in the Community. Clinical Pediatrics XX(X) 1–7. 2010. 25. González-Herrera L, Gamas-Trujillo P A. Identificación de deleciones en el gen de la distrofina y detección de portadoras en familias con distrofia muscular de Duchenne/Becker. Rev Neurol. 2009;48:66-70. 26. Hornyak J, Pangilinan P. Rehabilitation of Children and Adults Who Have Neuromuscular Diseases. Phys Med Rehabil Clin N Am. 2007;18:883-97. 27. Bushby K, Finkel R. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9:177-89. 28. Jansen M, De Groot M. Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study. Jansen et al. BMC Pediatrics 2010; 10:55. 29. Hornyak JE 4th, Pangilinan PH Jr. Rehabilitation of children and adults who have neuromuscular diseases. Phys Med Rehabil Clin N Am. 2007;18:883-97. 30. Bushby K, Finkel R, Birnkrant D J, Case L E, Clemens P, Cripe L. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. The Lancet Neurology. 2010;9(2):177-89. 31. Jansen et al. Physical training in boys with duchenne muscular dystrophy: the protocol of the no use is disuse study. BMC pediatrics. 2010. • texto online: http://www.biomedcentral.com/1471-2431/10/55 32. Mannlein J, Pangilinan P. Wheelchair seating for children with Duchenne muscular dystrophy , journal of pediatric rehabilitation medicine: an interdisciplinary approach. 2008;1(3):225-35. 33. Duchenne muscular dystrophy Advances in therapeutics; published in 2006 by taylor&francis group , 270 madison avenue, new york, ny 10016 34. Mcdonald C M, Carter G, Fowler W et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil. 1995;74:70-92. 35. Bar-or O, Rowland TW: Neuromuscular and musculoskeletal diseases. In Pediatric Exercise Medicine From Physiologic Principles to Health Care Application. Edited by: Bar-or O, Rowland W. Human Kinetics; 2004:269-303. 36. Akeson W, Amiel D, Abel M, Garfin S, Woo S. Effects of immobilization on joints. Clinical Orthopaedics and Related Research. 1987;219:28–37. 37. Booth F W. Physiologic and biochemical effects of immobilization on muscle. Clinical orthopaedics and related research. 1987;219:15-9. 38. Colliandereb T. Effects of detraining following short term resistance training on eccentric and concentric muscle strength. Acta Physiol Scand. 1992;144:23-9. 39. Hainaut K, Duchateau J. Muscle fatigue, effects of training and disuse. Muscle & Nerve. 1989;12:660-9. 40. Kottkef J. The effects of limitation of activity upon the human body. JAMA. 1966;196:117-22. 41. Muller E A. Influence of training and of inactivity on muscle strength. Arch Phys Med Rehabil. 1970;51:449-62. 42. Robinson G A, Stuart D G. Immobilization-induced changes in motor unit force and fatigability in the cat. Muscle & Nerve. 1991;14:563-73. 43. Bach J, Mckeon J. Orthopedic surgery and rehabilitation for the prolongation of bracefree ambulation of patients with Duchenne muscular dystrophy. American Journal of Physical Medicine and Rehabilitation. 1991;70:323-31. 44. Fowler W M. Rehabilitation management of muscular dystrophy and related disorders: i. The role of exercise. Arch Phys Med Rehabil. 1982;63:319-21. 45. Gardner-medwin D. Management of muscular dystrophy. Physiotherapy. 1977;63:46-55. 46. Harris S E, Cherry D B. Childhood progressive muscular dystrophy and the role of physical therapy. Physical Therapy. 1974;54:4-12. 47. Brooke M H, Fenichel G M, Griggs R C et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology. 1989;39:475-81. 48. Johnson E W, Walter J. Zeiter lecture: pathokinesiology of Duchenne muscular dystrophy: implications for management. Arch Phys Med Rehabil. 1977;58:4-7. 49. Sutherland D H, Olshen R, Cooper l, et al. The pathomechanics of gait in duchenne muscular dystrophy. Dev Med Child Neurol. 1981;23:3-22. 50. Archibald K C, Vignosp J. A study of contractures in muscular dystrophy. Arch phys med rehabil. 1959;40:150-57. 51. Johnson E R, Fowler W, Lieberman J. Contractures in neuromuscular disease. Arch Phys Med Rehabil. 1992;73:807-10. 52. Hsu J D, Furumasu J. Gait and posture changes in the Duchenne muscular dystrophy child. Clin Orthop Relat Res. 1993;288:122-25. 53. Dubowitz V. Progressive muscular dystrophy: prevention of deformities. Clin Pediatr. 1964;12:323-8. 54. Dubowitz V. Prevention of deformities. Isr J Med Sci. 1977;13:183-8. 55. Vignosp J. Physical models of rehabilitation in neuromuscular disease. Muscle & Nerve. 1983;6:323-38. 56. Siegel I M, Weiss L A. Postural substitution in duchenne’s muscular dystrophy. JAMA. 1982;247:584. 57. Owler W. Rehabilitation management of muscular dystrophy and related disorders. Comprehensive care. Arch Phys Med Rehabil. 1982;63:322-8. 58. Hyde S A, Fløytrup I, Glent S et al. A randomized comparative study of two methods for controlling tendoachilles contracture in Duchenne muscular dystrophy. Neuro Muscul Disord. 2000;10:257-63. 59. Johnson E W, Kennedy J. Comprehensive management of Duchenne muscular dystrophy. Arch Phys Med Rehabil. 1971;52:110-14. 60. Eagle M, Baudouin S V, Chandler C, Giddings D, Bullock R, Bushby K. Survival in duchenne muscular dystrophy: improvements in lifeexpectancy since 1967 and the impact of home nocturnal ventilation. Neuro Muscul Disord. 2002;12:926-9. 61. Jones D A, Rutheford O. Human muscle strength training: the effects of three different regimes and the nature of the resultant changes. J Physiol. 1987;391:1-11. 62. Edstrom L, Grimby L. Effect of exercise on the motor unit. Muscle & Nerve. 1986;9:104-26. 63. Alway S E, Macdougall J, Sale D et al. Functional and structural adaptations in skeletal muscle of trained athletes. J Appl Physiol. 1988;64:1114-20. 64. Cote C, Simoneau J, Lagasse P et al. Isokinetic strength training protocols: do they show 132induce skeletal muscle fiber hypertrophy? Arch Phys Med Rehabil. 1988;69:281-5. 65. Herbison G et al. Exercise of normal muscle: biochemical effects. Arch Phys Med Rehabil. 1973;54:409-15. 66. Luthi J, Howald H, Claassen H et al. Structural changes in skeletal muscle tissue with heavyresistance exercise. Int J Sports Med. 1986;7:123-7. 67. Adams M A, Chandler L. Effects of physical therapy program on vital capacity of patients with muscular dystrophy. Physical Therapy. 1974;54:494-6. 68. Hortobagyi T, Katch F. Role of concentric force in limiting improvement in muscular strength. J Appl Physiol. 1990;68:650-8. 69. Holloszy J. Muscle metabolism during exercise. Arch Phys Med Rehabil. 1982;63:231-4. 70. Sockolov R, Irwin B, Dressendorfer R, Fowler W. Exercise performance in 6 to 11 year old boys with duchenne muscular dystrophy. Arch Phys Med Rehabil. 1977;58:195-201. 71. Bennett R, Knowlton G. Overwork weakness in partially denervated skeletal. Muscle Clin Orthop. 1958;22-9. 72. Balnave C, Thompson M. Effect of training on eccentric exerciseinduced muscle damage. J Appl Physiol. 1993;75:1545-51. 73. Clarkson P, Kazuno R, Braun B. Muscle function after exerciseinduced muscle damage and rapid adaptation. Med Sci Sports Exerc. 1992;24:512-20. 74. Duchateau J, Hainaut K. Isometric or dynamic training: differential effects on mechanical properties of a human muscle. J Appl Physiol. 1984;56:296-301. 75. Hather B, Tesch P, Buchanan P et al. Influence of eccentric actions on skeletal muscle adaptations to resistance training. Acta Physiol Scand. 1991;143:177-85. 76. Byrd S K. Alterations in the sarcoplasmic reticulum: a possible link to exercise-induced muscle damage. Med Sci Sports Exerc. 1992;24:531-6. 77. Clarkson P, byrneswc, mccormick km, et al. Muscle soreness and serum creatine kinase activity following isometric, eccentric, and concentric exercise. Int J Sports Med. 1986;7:152-7. 78. Clarkson P, Tremblay I. Exercise-induced muscle damage, repair, and adaptation in humans. J Appl Physiol. 1988;65:1-6. 79. Friden j, lieberrl. Structural and mechanical basis of exercise-induced muscle injury. Med sci sports exerc 1992;24:521–30. 80. Leiber R, Friden J. Muscle damage is not a function of muscle force but active muscle strain. J Appl Physiol. 1993;74:520-6. 81. Mccully K, Shellock F, Bank W et al. The use of nuclear magnetic resonance to evaluate muscle injury. Med Sci Sports Exerc. 1992;24:537-42. 82. Mcneil P, Khakee R. Disruptions of muscle fiber plasma membranes: role of exerciseinduced damage. Am J Path. 1992;140:1097-109. 83. Sacco P, Jones D, Dickjrt et al. Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle. Clin Sci. 1992;82:227-36. 84. Carter G, Kikuchi N, Abresch R, Walsh S, Horasek S, Fowler W. Effects of exhaustive concentric and eccentric exercise on murine skeletal muscle. Arch Phys Med Rehab. 1994;75(5):555-9. 85. Carter G, Wineinger M, Walsh S, Horasek S, Fowler W. Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neuro muscul disord. 1995;5(4):323-31. 86. Aitkens S, Mccrory M, Kilmerd D et al. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1993;74:711-5. 87. Bohannon R, Jones P. Results of manual resistance exercise on a manifesting carrier of duchenne muscular dystrophy: A case report. Phys Ther. 1986;66:973-5. 88. Delateur B, Giaconi R. Effect on maximal strength of submaximal exercise in duchenne muscular dystrophy. Am J Phys Med. 1979;58:26-36. 89. Dimarco A F, Kelling J S, Dimarco M et al. The effects of inspiratory resistive training on respiratory muscle function in patients with muscular dystrophy. Muscle & Nerve. 1985;8(4):284-90. 90. Dupont-versteegden E, Mccarter R, Katz M. Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice. J Appl Physiol. 1994;77:1736-41. 91. Dscalante A, Miller L, Beardmore T. Resistive exercise in the rehabilitation of polymyositis/ dermatomyositis. J Rheum. 1993;20:1340-4. 92. Florence J, Hagberg J M. Effect of training on the exercise responses of neuromuscular disease patients. Med Sci Sports Exerc. 1984;5:460-5. 93. Hicks J, Miller F, Plotz P, et al. Isometric exercise increases strength and does not produce sustained creatinine phosphokinase increases in a patient with polymyositis. J Rheu. 1993;20:1399-401. 94. Kawazoe Y, Kobayashi M, Tasaka T et al. Effects of therapeutic exercise on masticatory function in patients with progressive muscular dystrophy. J Neurol Neurosurg Psychiatry. 1982;45:343-7. 95. Kilmer D, Mccrory M, Wright N et al. The effect of high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1994;75:560-3. 96. Iohi E, Lindber C, Andersen O. Physical training effects in myasthenia gravis. Arch Phys Med Rehabil. 1993;74:1178-80. 97. Mccartney N, Moroz D, Garner S et al. The effects of strength training in show 132 patients with selected neuromuscular disorders. Med Sci Sports Exerc. 1988;20:362-8. 98. Milner-brown H, Miller R. Muscle strengthening through highresistance weight training in patients with neuromuscular diseases. Arch Phys Med Rehabil. 1988;69:14-9. 99. Martin R, Sufit R, Ringle S et al. Respiratory improvement by muscle training in adultonset acid maltase deficiency. Muscle & Nerve. 1983;6:201-3. 100. Scott O, Hyde S, Goddard C et al. Effect of exercise in Duchenne muscular dystrophy. Physiotherapy. 1981;67:174-6. 101. Spector S, gordonpl, et al. Strength gains without muscle injury after strength training with postpolio muscular atrophy. Muscle & Nerve. 1996;19:1282-90. 102. Spector S, Lemmer J, Koffman B et al. Safety and efficacy of strength training in show 132 patients with sporadic inclusion body myositis. Muscle & Nerve. 1997;20:1242-8. 103. Taylor R, Fowler W, Doerr l. Exercise effect on contractile properties of skeletal muscle in mouse muscular dystrophy. Arch Phys Med Rehabil. 1976;57:174-80. 104. Vignos P, Watkins M. The effect of exercise in muscular dystrophy. JAMA. 1966;197:121-6. 105. Webster C, Silberstein L, Hays A, Blau H. Fast muscle fibers are preferentially affected in duchenne muscular dystrophy. Cell. 1988;52(4):503-13. 106. Tardieu C, Lespargot A, Tabary C et al. For how long must the soleus muscle be stretched each day to prevent contracture? Developmental medicine and child neurology. 1988;30:3-10. 107. Cusick B. Splints and casts: managing foot deformity in children with neuromotor disorders. Physic Ther. 1988;68:1903-12. 108. Bar-or O. Role of exercise in the assessment and management of neuromuscular disease in Children. Med Sci Sports Exerc. 1995;28:421-7. 109. Edwardsr H. Studies of muscular performance in normal and dystrophic subjects. Brit Med Bull. 1980;36:159-64. 110. Haller R, Lewis S. Pathophysiology of exercise performance in muscle disease. Med Sci Sports Exerc. 1984;16:456-9. 111. Lewis S. Exercise and human neuromuscular diseases: a symposium overview. Med Sci Sports Exerc. 1984;16:449-50. 112. Wright N, Kilmer D, Mccrory M et al. Aerobic walking in slowly progressive neuromuscular Disease: effect of a 12-week program. Arch Phys Med Rehabil. 1996;77:64-9. 113. American college of sports medicine. In: guidelines for exercise testing and prescription. 4th ed. Philadelphia: lea & febiger; 1991. Páginas 11-32. 114. Mcdonald C M, Widman L, Walsh D, Walsh S, Abresch R. Use of step activity monitoring for continuous physical activity assessment in boys with duchenne muscular dystrophy. Arch Phys Med Rehabil. 2005;86:802-8. 115. Carter G T, Abresch R, Fowler W. Adaptations to exercise training and contraction-induced muscle injury in animal models of neuromuscular disease. Am J Phys Med Rehabil. 2002;81:151-161. 116. Lim J, Kim D, Bang M. Effects of exercise and steroid on skeletal muscle apoptosis in the mdx mouse. Muscle & Nerve. 2004;30:456-62. 117. Bush B. The multidisciplinary management of duchennemuscular dystrophy, Curr Pediat. 2005;15(4):292–300. 118. Pellegrini N, Guillon B, Prigent H et al., optimization ofpower wheelchair control for patients with severe duchennemuscular dystrophy, Neuro Muscul Disord. 2004;14(15):297-300. 119. Clark J, Michael S, Morrow M. Wheel chair postural support For young people with progressive neuromuscular disorders. Int J Therapy Rehabil. 2004;11(8)365–373. 120. Engstrom E D. Ergonomics, wheelchairs and positioning, Sweden: brommatryck, ab; 1993 121. Bakker J, de Groot I J, Beelen A, Iankhorst G. Predictive factors of cessation of ambulation in patients with duchenne muscular dystrophy, Am J Phys Med Rehabil. 2002;81(12):906-12. 122. Guerette P, Tefft D, Furumasu J. Pediatric powered wheelchairs: results of a national survey of providers. Assist Technol. 2005;17(2):144-58. 123. Mcdonald C. Limb contractures in progressive neuromuscular disease and the role of stretching, orthotics, and surgery. Phys Med Rehabil Clin N Am. 1998;9:187-211. 124. Siegel I. Plastic-molded knee-ankle-foot orthoses in the treatment of duchenne muscular dystrophy. Arch Phys Med Rehabil. 1975;56:322. 125. Bakker J, de Grooti J, de Jong B et al. Prescription pattern for orthoses in the netherlands: use and experience in the ambulatory phase of duchenne muscular dystrophy. Disabil Rehabil. 1997;19:318-25. | |
